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In earlier studies on the mechanism of immunity to the viruses of Eastern 
(E.E.E.)  or  Western  equine  encephalomyelitis  (W.E.E.),  it  was  possible, 
under certain experimental conditions, to demonstrate a  quantitative correla- 
tion betwee degree of cerebral resistance of vaccinated mice and titer of neu- 
tralizing antibody in their serum (1).  The high serum titer generally required 
to insure resistance to intracerebral challenge was believed to be due to pene- 
tration of only a  small fraction of serum antibody into the central nervous 
system since the serum/brain tissue/spinal fluid ratio for antibody titers in 
vaccinated rabbits was of the order of 300/3/1  (2). 
However, when the response of immunized rabbits or guinea pigs to an intra- 
cerebral inoculum was studied in some detail (3), it was found that the serum/ 
brain antibody ratio was not unalterably fixed.  The inoculation was followed 
first by a febrile response closely resembling that of non-vaccinated animals. 
In some instances, there were also transitory signs of damage to the central 
nervous system.  It was possible to isolate the virus from the brains of a few 
guinea pigs during this abortive  attack,  but  attempts  to  demonstrate viral 
multiplication failed repeatedly.  In one experiment, the rise and fall in neu- 
tralizing titers of sera and brains was followed after challenge inoculation, and 
it was found that at 1 week the brain titer had risen so high that the serum/brain 
ratio had been reduced from about 100/1 to 1/1 and 10/1, respectively, in the 
two animals tested. 
It seemed possible that such high neutralizing titers of brain tissue, if repro- 
ducible, might be of significance in relation to the survival of immune animals. 
This was suggested, in particular, by the finding (4) that the degree of resistance 
of vaccinated mice to W.E.E. virus depended on the rate of multiplication of 
the strain used as challenge inoculum.  This difference in response indicated 
that the concentration of antibody present at the time of challenge was certainly 
not the sole factor determining the fate of the immune animal.  It was likely 
that the intracerebral inoculum served as an antigenic booster and that the 
effectiveness of the resulting antibody response depended on the rate of viral 
multiplication.  Experiments in this direction were carried out in mice because 
it was desirable to use large numbers of animals, and because the growth rates 
5o7 508  MECHANISm  OF  IMMUNITY  TO  ENCEPHALOMYELITIS  VIRUS.  II 
of viral variants were being studied in that host (4).  This paper will deal with 
the following aspects:  (a) the fate of a "fast" and a "slow" virus strain in the 
immune host; (b) the antigenic booster effect of the challenge inoculum; (c) the 
nature of the neutralizing substance  found in brain tissue. 
Materials and Methods 
The R.I. and the Kelser strains of W.E.E. virus were used as representing 
"fast" and "slow" variants of the virus.  Their characteristics  and most of 
the other materials and methods used have already been described (4). 
Serological Tests.--Test material for serological study was obtained as follows: Mice were 
exsanguinated from the heart, and then their heads were perfused slowly with at least l0 ml. 
of saline.  The efficacy  of perfusion was tested by suspending homogenized perfnsed normal 
brain tissue in 2.2 parts of distilled water (1:3.2) and then clarifying the suspension in the 
cold for 30 minutes at about 13,000 ~.P.~. in an angle centrifuge.  1  The supernatant fluid was 
water-clear and colorless indicating the absence of detectable hemolysis. 
Brains to be tested for antibody were kept frozen in lusteroid tubes.  For test, they were 
ground up in 2.2 ml. per gin. of tissue of either saline containing 2 per cent of normal guinea 
pig serum previously heated at 56°C. for 30 minutes, or plain saline.  The resulting suspen- 
sions were used either uncentrifuged or centrifuged for 30 minutes at 13,000  R.p.~r.  Neu- 
tralization tests with crude suspensions and supernatant fluids yielded identical results. 
(a)  Tevhnique and Interpretation of Neutralization Tests.--Setial  0.5 log-fold (actually 3.2- 
fold) dilutions of serum or brain extract were mixed with equal parts of 2 ×  10  "-s diluted R.I. 
stock virus.  The mixtures were held for 2 hours in the 37°C. water bath, and then 0.03 ml. 
was inoculated intracerebrally into groups of 4 to 6 mice per dilution.  Control mixtures with 
normal mouse serum or brain extracts were always injected last. 
The final concentration of virus in the mixtures (10  -s) represented 101"~ LD50/0.03 ml., 
since, as shown in the earlier paper (4), the mean titer of this virus was 109 "u LDs0/0.03 gin. 
of brain tissue.  In the period during which neutralization tests were carried out, a  total of 
36 control titrations were performed in which the 10  -s dilution was included.  The number of 
mice used per test ranged from 4 to 10.  Of 169 mice inoculated, only 4 survived; in 36 tests, 
there were only 3 in which 20 to 25 per cent of the mice survived (1 of 4, 1 of 5, 2 of 10, respec- 
tively).  The odds, therefore, of 1 of 4, 1 of 5, or 1 of 6 mice surviving may be considered as 
1 in 10,  1 in 8,  1 in 7 tests, respectively.  The chance of 2 surviving in such groups would 
have been less than 1 in 100 or 1 in 1,000.  Therefore, in neutralization tests the occurrence 
of 2 or more survivors in a group of mice may be considered as due to specific neutralization. 
However, deaths may be scattered among mice inoculated with "neutral" mixtures containing 
antibody dilutions over the entire effective range, the mortality rate not necessarily increasing 
with decreasing concentration of antibody.  This variation in response of individual mice to 
a given inoculum makes difficult the determination of the actual limiting neutralizing dilution. 
If an adequate range of dilutions and enough animals are used, consistent and reproducible 
titers are obtained by applying the method of Reed and Muench (5) to calculate the cumula- 
tive 50 per cent survival end-point, or the estimated highest (final) dilution which, when 
injected together with 101 '~ LDs0 of virus, would protect 50 per cent of the mice (NDs0). 
(b)  The Serum/Brain Ratio of Neutralizing Antibody in Immunized  Mice.--The methods 
just described can best be illustrated by an example which, at the same time, will show the 
"normal" serum/brain ratio in mice immunized by intraperitoneal inoculation of  W.E.E. 
vaccine. 
a A Sorval angle centrifuge with a 9 inch head was used. a.  w.  SC~I.v.snqo~R  509 
Mice were immunized with a  total of 0.17 ml. of vaccine, a  relatively large dose.  Two 
weeks after the first dose, they were exsangninated and perfused, and their brains and sera 
were tested for neutralizing antibody. 
TABLE  I 
Comparative Neutralizing  Tigers of Serum  and Brain Tissue  of Hyperimmunized Mice against 
10  t'~ LD6o of W.E.E. Virus 
SenllIl  Rate of survival of mice  Ratio -- 
Test  Brain 
Mouse No.  material  Log NDjo* 
Log final dilution of serum or brain in mixture  Log  Antilog 
0.8  1.3  1.8  2.3  2.8  3.3  3.8 
Serum  4/4~  3/3  3/4  4/4  "2/4  --  >3.20§  >252 
1  Brain  0/4  1/4  1/4  <0.80[[  >2.40  1 
q 
Serum  --  2/4  4/4  3/3  2/4  3/4  --  >2.95  >142 
2  Brain  2/4  0/4  0/4  0.80  >2.15  1 
Serum  --  3/4  4/4  4/4  3/4  2/4  --  >3.07  >132 
3  Brain  3/4  0/4  0/4  0.95  >2.12  1 
Serum  4/6  5/6  4/6  3/6  3/6  >3.30  >282 
4  Brain  3/6  1/6  0.85  >2.45  -  1 
Serum  3/6  5/6  6/6  3/6  1/6  3.10  178 
5  Brain  3/6  1/6  0.85  2.25,  T 
Mean 1,2,3,  Serum  >3.12  >2.27  >186 
4, 5  Brain  <0.85  1 
1,  2,  3,  4,  5  Serum  5/5  5/5  4/5  0/5  3.49  2.29.  195 
pooled  Brain  3/5  3/5  0/5  1.20  1 
Total dosage of vaccine (7 doses) -~ 0.17 ml. intraperitoneally. 
* ND60  -- estimated highest dilution of test material which would protect 50 per cent of 
the mice. 
Fractions indicate number of mice surviving in numerator, number inoculated in de- 
nominator. 
§ >3.20, no end-point; NDs0 ffi 3.20 or higher. 
II <0.80, no end-point; estimate of NDs0 based on assumption that with lower dilutions of 
antibody all mice would survive. 
The results are given in Table I.  While end-points were not obtained in all fitrations 
of individual sera, the approximate mean serum/brain ratio for the 5 mice studied was similar 
to that obtained in a test with pooled materials from all 5 animals.  A ratio of the order of 
200/1 is in close accord with that described earlier (2) for rabbits vaccinated with W.E.E. 
virus.  Similar values have also been found by Freund (6) for bacterial antibody in rabbits 
and by Fox (7) for yellow fever antibody in mice vaccinated by extranenral routes.  2  Since 
2 For the purpose of comparison, the ratios given by Fox (7) should be multiplied by 10, 
since 10 per cent brain suspensions served as starting materials in his titrations. ~i0  ~ECiZA_NISM  OF IMMUNITY  TO ENCEPHALOMYELITIS  VIRUS.  II 
Freund found that this ratio is established shortly after  either intravenous (6) or intracis- 
ternai (8) injection of antibody, one may assume that it expresses an equilibrium between 
plasma and brain tissue under normal  physiological conditions.  Accordingly,  there were 
only a few exceptional tests in which the lowest dilutions of brain tissue from immunized 
mice neutralized even though the corresponding serum titer was less than 1:1,000. 
(¢) Technique of Complement Fixation Teas.--Brain suspensions serving as source of com- 
plement-fixlng  antibody were prepared as described above.  They were heated for 20 minutes 
in the 60°C. water bath and then centrifuged for 30 minutes at 13,000 l~.P.m.  The resulting 
supernatant was water-clear and colorless.  Sera were diluted 1: 4 or higher in saline, heated 
at 60°C. for 20 minutes, and then also centrifuged for 30 minutes at 13,000 R.P.~. 
Eastern and Western E.E. antigens were obtained from the Lederle Laboratories, Inc. 
Tests were set up with 0.1 ml. of antigen, 0.1 mh of serum or brain dilution, 0.2 ml. con- 
taining  2 hemolytic units of complement, and 0.2 ml. of sensitized sheep erythrocytes, and the 
technique used was that recommended by Casals (9).  Titers have been expressed in terms of 
highest original dilutions of test material giving 2 plus or greater fixation. 
EXPEI~  IME~NTAL 
Fate of W.E.E. Virus after Intracerebral Inoculation in Immune Mice 
For a study on the fate of W.E.E. virus in the brains of immunized anlm~ls, 
it was  desirable to  contrast the response to a  "fast"  variant with that to a 
"slow" one.  Therefore, mice were vaccinated to a  degree at which they were 
expected to resist the "slow" but not the "fast" inoculum.  The dependence 
of demonstrability of this strain difference on the level of immunity has been 
described elsewhere (4). 
Accordingly, mice received intraperitoneaily a total of 0.018 ml. of vaccine.  Four weeks 
after the first dose, 33 received intracerebraily  105a LDs0 of the "fast" R.I. strain, and 39 
10  ~'5 LD60 of the "slow"  Kelser strain.  Non-vaccinated mice of the same age  served as 
controls.  Of the mice challenged with the R.I. strain, 9 were sacrificed at various intervals 
up to the 3rd,  day.  The remaining 24 died from 2 to 11 days (average 3.7 days) after inocula- 
tion.  Of those challenged with the Kelser strain, 35 were sacrificed at various intervals up 
to 114 days after inoculation.  None showed any signs of illness.  Mice from the control 
groups were sacrificed at corresponding intervals as long as survivors were left. 
Thus, vaccinated mice were resistant to 105"5 LD60 of the slow strain but not 
to 10  s'~  LDs0 of the fast one. 
All mice were perfused except those sacrificed before the 3rd day after chal- 
lenge inoculation.  The brains were used in tests for virus or antibody content. 
The fate of the virus in the brain was followed in the manner already de- 
scribed (4) for experiments on viral multiplication.  Brains of individual  mice 
were titrated.  The range of titers is given for the R.I. strain in Fig. 1, for the 
Kelser strain in Fig.  2.  The curves for the  2  strains in the non-vaccinated 
groups were comparable with those described in detail elsewhere (4).  In vac- 
cinated mice, the rate of multiplication of the  "fast"  variant paralleled that 
in non-vaccinated controls but at  a  lower  level  (Fig.  1).  Inasmuch as  the 
brains at 3 hours and at 1 and 2 days were not perfused, it is possible that the R.  W.  SCHLESINGER  51I 
difference between normal and vaccinated mice may have been largely the re- 
sult of in ~itro neutralization. 
On  the  other  hand,  in  the  vaccinated group  challenged with  the  "slow" 
strain, there was a  much more marked depression in the titer of demonstrable 
virus (Fig. 2).  Nevertheless, multiplication apparently occurred, and in some 
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FIG. 1.  Multiplication  of W.E.E.  virus, "fast"  R.I. strain,  in brains of normal and of 
vaccinated mice. 
animals the virus maintained itself for 4  days at a  level lO0-fold higher than 
that found at 3 hours. 
Because of the small number of specimens available in this test and because of  the im- 
portance attached  to the unequivocal demonstration of viral multiplication in immune ani- 
mals, another experiment was done in which mice imm-nlzed with a total of 0.015 ml. of 
vaccine were challenged with 10  s'5 LD60 of the "slow" strain.  Brains were harvested at 3 
hours and at 2 days from 9 mice each.  Of 30 additional mice, only one succumbed, and the 
group as a whole may be considered as resistant.  At each interval, 3 pools of 3 brains each 
were fitrated for virus.  The results of these titrations are presented in Table II.  It will be 
seen again that there was about a 100-fold increase in virus at 2 days in the brains of vac- 
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Thus, immunity of a  degree high enough to insure resistance to challenge 
did not preclude transitory multiplication of the challenge virus.  However, 
while  some factor arrested further multiplication of the  "slow"  strain,  this 
factor failed to operate effectively when the challenge virus multiplied rapidly. 
The following sections will deal with the experimental evidence identifying this 
factor as neutralizing antibody believed to be produced locally in response to 
the challenge inoculum. 
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FIG. 2. Multiplication  of W.E.E. virus,  "slow" Kelser  strain,  in brains  of normal and of 
vaccinated  mice. 
Changes in the Serum~Brain Antibody Ratio in Vaccinated Mice after 
Intracerebral Challenge Inoculation 
In continuation of the first experiment described above, the sera and brains 
obtained from mice at various intervals after challenge inoculation with the 
"slow" Kelser strain were tested for neutralizing antibody.  The outcome of 
these tests is presented in Table III and Fig. 3. 
A pool  of 9 sera collected  from vaccinated but unchallenged mice at the time of challenge 
had a neutralizing titer of 1.8 log (1:64).  As expected, with a serum titer of such low order, R.  W.  SCHLESINGER  513 
no significant amounts of antibody could be measured in the corresponding brains even though 
they were not perfused.  Only 3 of them, when tested individually, neutralized in the lowest 
dilution tested (1:6.4).  Beginning on the 5th day after challenge, the brain titer increased 
out of proportion to the serum titer with a resulting marked shift in the serum/brain ratio. 
The brain titer was maintained on a high level from the 7th to at least the 114th day, the 
ratio decreasing from the "normal" value of about 200/1 to 16/1 on the 6th day to less than 
10/1 from the 13th day on.  It is particularly noteworthy that the neutralizing titer of brain 
tissue was relatively high on the 5th day in view of the fact that brains harvested on the 4th 
day had contained considerable amounts of virus (see Fig. 2). 
TABLE II 
Multiplication of W.E.E. Virus, "Slow" Strain, in Brains of Immune and of Normal Mice 
Dose of 
vaccine 
0.015 ml. 
None 
Time sac- 
riticed after 
intracerebral 
inoculation 
IllS. 
3 
48 
48 
Lot 
A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
K 
No. of brains 
Log LD•  recovered 
Single lots  Mean 
3.16 
3.25  3.18 
3.12 
5.16 
4.62  4.98 
5.08 
3.61 
3.25  3.41 
3.36 
6.50  6.32  6.14 
Mean 
increase ,3 
to 48 hrs. 
1.80 
2.91 
Challenge inoculum, 106"~ LDs0. 
Thus, in animals with a relatively low degree of initial immunity (as indicated 
by a  serum titer of 1:64 just before challenge with virus) the multiplication of 
a  large inoculum of the "slow" strain was arrested, and neutralizing antibody 
appeared in the brain in excess before the virus had spread to an extent incom- 
patible with the animal's recovery.  A causal relationship between the accumu- 
lation of antibody in the brain and survival of the animal is suggested by the 
fact that other animals in the same experiment failed to resist a  comparable 
dose of the "fast" variant which attained lethal concentrations well before the 
5th day (see Fig. 1). 
As a  corollary, in an attempt to show whether or not the neutralizing sub- 
stance found in brain tissue was antibody, some of the brain suspensions and 514  MECHANXSM  OF IMMUNITY TO ENCEPHALOMYELITIS VIRUS.  II 
TABLE III 
Tilers of Neutralizing Antibody in Sera and Brains of Vaccinated  Mice before and after 
Intracerebral  Challenge Inoculation 
Time after 
challenge 
inoculaUon 
days 
5 
7 
10 
13 
24 
55 
114 
Log ND6o 
Serum  I  Brain 
Single or repeated  Mean  Single or repeated 
tests  tests 
Serum*  Mean ratio --  Brain 
Mean  Log  Antilog 
2.60,  2.55:~  2.58 
m 
3.10,  2.60 
3.02,  2.30 
2.90 
2.8O '2.70 
2.80 
2.55 
2.70 
2.85 
2.66 
2.80 
2.53 
1.42  1.42  --  -- 
1.42 
0.92 
<1.17  >16.6 
<1.36  >1.22  1.87  1 
1.49 
1.72,  1.65  1.69  --  -- 
2.82 
2.52  --  -- 
2.22 
2.17,  1.77  1.89  0.96.  9"--! 
1.82  1 
1.82~  7.8 
2.07~1.59  1.77  0.89.  -T- 
1.42 ]  6...._~2  2.17~2.02  2.01  0.79. 
2.42 /  ,  1 
1.98  O.  4__55 
1. 8O 
65 
2.15  1 
Total d0sage of vaccine, 0.018 ml.  Challenge dose, 10s'5  LDs0 of "slow" variant. 
* A pool of 9 sera obtained before challenge inoculation gave a mean ND60 of 1.8 (1:64); 
The corresponding brains were not perfused, and only 3 of the 9 showed  some evidence of 
neutralization  in the lowest dilution tested (1:6.4).  The prechallenge ratio therefore could 
notbe determined and is assumed to be of the usual order; i.e., about 200/1. 
:~ Braces indicate that pools were tested. 
For further explanation  see Table I. 
sera  were  tested  for  complement-fixing antibody.  The  results  are  shown  in 
Table IV.  Complement-fixing antibody was first demonstrated in the brains 
of mice sacrificed on the 10th day after intracerebral inoculation.  On the 13th 
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day both  serum  and  brain  titers were  at  maximum,  and  the  ratio was  8/1. 
Thereafter, both titers fell, but the ratio remained at 8/1 on the 24th day and 
at 4/1 on the 55th day. 
Assuming  that  a  "physiological" serum/brain  ratio  of  the  order of  200/1 
applies to complement-fixing antibody as it does to other types of antibody, 
the shift in neutralizing titers was paralleled by a  similar shift in complement- 
fixing titers. 
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Fio. 3.  Titers of neutralizing antibody in sera and brains of vaccinated mice before and 
after intracerebral challenge inoculation. 
Further Evidence  that the  Neutralizing Substance in Brain  Tissue Is Antibody 
(a) The Specificity of the Antibody  in Brain Tissue.--Equal parts of Eastern and Western 
E.E. vaccines were mixed, and 36 mice were given intraperitoneally  a total of 0.15 ml. of the 
mixture.  Two weeks after the first dose of vaccine, 6 mice  were sacrificed, 15 received intra- 
cerebrally 104"6 LD~0 of E.E.E. stock virus and the remaining 15 by the same route 105"~ 
LD50 of the  "fast"  R.L  strain of W.E.E. virus.  At 2 weeks after clmllenge  inoculation, 
there were 8 survivors in the E.E.E. group, but only 3 in the W.E.E. group.  All these were 
bled from the heart,  perfused, and  their  brains were  harvested.  Sera and  brains were 
pooled in  lots  as  indicated in Tables V  and VI  and  titrated for neutralizing antibody 
against W.E.E. virus and  for  complement-fixing  antibody against both the Eastern and 
Western types. 
The result of the  neutralization  test is summarized in Table  V.  The  out- 
standing  finding  is  that  after  challenge  with  W.E.E.  virus,  the  homologous 
titer of brain tissue rose to at least the same level as that of the serum, while 
after challenge with E.E.E.  virus, the Western antibody remained unchanged 
in both  serum  and  brain tissue.  This  finding, as will be  discussed later on, 516  MECHANISM  OF  IMMUNITY  TO  ENCEPHALOMYELITIS  VIRUS.  II 
confirms the belief that  the accumulation of antibody in the brain is the result 
of local production. 
TABLE  IV 
The Rise and  Fall of Complement-Fixing Antibody  in Serum and Brain  Tissue  of Immune 
Mice before and after Intracorebral Challenge with 10  5"5 LDso of the "Slom" Strain of 
W.E.E. Virus 
10 
13 
24 
55 
114 
Antigen 
Interval after  No. 
intracerebral  of  Test  W.E.E.  !  E.E.E. 
challenge  mice  material 
Dilution of test material 1: 
4  8  16  32  64  128  256  512  4  8  3: 
Serum  3  +_.  0 
9  Brain  0  0 
Serum  4  4  4  4  3  0 
4 
Brain  0  0  0  0 
1  Brain  --  0*  0  0  0  0  0  -- 
2  Brain  --  3*  1  0  0  0  0 
Serum  --  4  4  4  4  4  3-4~  0 
2 
Brain  --  4*  4  8-4  0-2  0  0  0 
Serum  --  4  4  4  3-4  0  0  0 
2 
Brain  --  2-3  +__  0  0  0  0 
Serum  4  1  0  0  0 
3  Brain  3  1  0  +  0 
Serum  0  0  0  0  0 
5 
Brain  0  0  0  0  0  0  --  -- 
0 (before 
challenge) 
6 
7 
16 
0  0  ( 
+0 
0  0  ( 
0  0  ( 
--  0*  0  C 
0*  0  ( 
--  0  0  C 
--  0*  0  £ 
--  0  0  C 
0  0  C 
0  C 
0  0 
0  0 
0  C 
The results are presented as, 4  -- complete fixation; 0  =  complete hemolysis with inter- 
mediate degrees of fixation expressed as 3, 2, and 1.  The highest dilution giving a reading of 
at least 2 is considered as end-point (bold-faced type). 
* Indicates that the lowest dilution tested was 1 : 10 instead of 1 : 8. 
:~ Two figures indicate results of duplicate tests. 
In  Table  VI,  the outcome  of  the  complement  fixation  test  with  the  same 
materials is shown.  Here again,  the serum/brain  ratio for antibody  reacting 
with the virus used for  the intracerebral test was  reduced  to  2/1  to 8/1.  In 
these doubly immunized mice, the antibody  response to challenge was just as 
specific in the brain as in the serum. 
(b)  The Percentage Law.--Table  VII illustrates one of several tests in which 
constant amounts  of serum or brain extract of vaccinated and challenged mice R.  W.  SCHLESINGER  517 
were mixed with graded amounts of virus and in which the resulting mixtures 
after 2 hours' incubation at 37°C. were diluted serially so that the highest dilu- 
tion contained 10  -s virus.  It may be seen that in both cases the percentage of 
virus neutralized was independent of the amount of virus originally added to 
the test material.  In other words, the "percentage law" as described by Mer- 
TABLE V 
W.E.E. Neutralizing Antibody  in Serum and Brain Tissue of Mice Immunized against W.E.E. 
and E.E.E. Viruses before and 2 Weeks after Intraverebral Challenge InoculaZlon of 
Eil~r Virus 
S~cificity of the Local Response 
Challenge 
VIRUS 
None 
W.E.E. 
E.E.E. 
Lot 
A 
D 
E 
F 
No. of mice  Test material 
Serum 
Brain 
Serum 
Brain 
Serum 
Brain 
Serum 
Brain 
Serum 
Brain 
Serum 
Brain 
Log ND• 
2.15 
<0.70 
1.80 
1.02 
2.80 
>2.78 
1.80 
<0.65 
2.21 
<0.90 
2.07 
<1.27 
~gl'll.ffi 
ratio 
log 
>1.45 
0.78 
<0.02 
>1.15 
>1.31 
>0.80 
The lowest dilution of brain tissue tested was 10  -0.9 for lots A to E, and 10  -L4 for lot F. 
In some instances, there was a suggestion of neutralization  by these dilutions.  The estimated 
ND60 titers are unduly high because they are based on the assumption that with lower dilu- 
tions all mice would have survived. 
For explanation of symbols see Table I. 
rill (10)  for  Eastern E.E.  virus and its antibody and as  observed for  other 
antigen-antibody mixtures (11)  applied equally to the neutralizing substance 
in the brain and that in the serum. 
The Effect of Varying Degrees of Immunization on the Shift in Serum Antibody/ 
Brain Antibody Ratio after Intracerebral  Challenge 
Mice which had been immunized with graded amounts of W.E.E.  vaccine and had sur- 
vived  after  intracerebral  challenge inoculation of varying amounts of the "slow"  Kelser 518  MECHANISM  OF  TM~rlYNITY  TO  ENCEPHALOMYELITIS  VIRUS.  II 
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strain, were sacrificed at various intervals.  These  mice were survivors from the experiment 
described in Fig. 6 of the preceding  paper (4).  The sera and perfused brains were each pooled 
according to the amount of vaccine received.  Each pool contained specimens from mice 
challenged with 10  5, 10  a, and 101 LDs0 of virus. 
The results of a neutralization test with these pools are summarized in Table 
VIII.  It is shown that the relative concentration of antibody in the brain in- 
creased with decreasing dosage of vaccine used for immunization.  As a result, 
while all the  serum titers were of the  same order of magnitude,  there was a 
TABLE VII 
The "Percentage Law"  in the Neutralization of W.E.E. Virus by Immune Mouse Serum and 
Brain Tissue 
Test material 
Immune serum 
[mmune brain 
Normal  mouse 
serum 
Original mixture: 
Final dilution of 
I Serumor brain 
lO-l.* 
lO-O.S 
10--1.a 
Survival rate in mice inoculated with 
Virus  Original 
mixture  10-t  10-5  10-  t  10  ~  lO-a 
Dilution of mixture to final virus 
concentration equivalent to: 
lO-i 
0/4  0/3  1/3  4/4  -- 
014  014  214  314  -- 
014  214  314  -- 
0/4  4/4  -- 
4/4  -- 
014  0/4  014  414  -- 
0/4  1/4  3/4  -- 
014  8/4  -- 
s/4  -- 
10  -3  0/4  0/4 
10  -4  0/4  -- 
10  -5  0/4 
10  -6  0/4 
~o  -7  s/4 
10  -s  3/4 
10  --4  0/4  -- 
10  -5  0/4 
10  -e  0/4 
lO  -7  1/4 
10  -s  2/4 
10  -a  0/4 
10  -a  0/4 
lo  --s  o14 
10  -9  3/4 
10  -1°  3/4 
0/4  0/4  3/4 
0/4  2/4 
tenfold difference between the serum/brain ratios in mice vaccinated with 1.8 
ml. of vaccine (ratio 24.6/1) and in those vaccinated with 0.0018 or 0.0057 ml. 
(ratio 2.3/1 or 2.8/1), with intermediate values for those vaccinated with 0.018 
or 0.057  ml.  A  single complement fixation test was carried out with pooled 
sera and brains from the latter 4 groups.  As shown in Table VIII, the ratio 
was 4/1 which is again in good agreement with that for the neutralizing titers. 
It is noteworthy that the time interval which elapsed after challenge inoculation 
did not influence the consistency of the pattern.  This is  in agreement with 
the experiment described earlier in which the ratio remained more or less con- 
stant from about the 13th to the ll4th day after inoculation. 520  ~C~mSM  OF  IMMUNITY  TO  ENCEPHALOMYELITIS  VIRUS.  II 
One may assume that in animals immunized with large amounts of vaccine 
a  considerable proportion of the challenge inoculum would be neutralized and 
thereby rendered incapable of multiplication and also less effective as antigen. 
Conversely, after vaccination with small doses, the primary antibody response 
may be minimal but the animal would be sufficiently sensitized to respond to 
the challenge virus with a  large and rapid local output of antibody.  By the 
same token, in highly immunized animals, survival may be largely due to the 
suppressive effect of antibody initially present which would be effective against 
either "fast" or "slow" variants of the virus (see Fig. 6 in reference 4).  In less 
TABLE VIII 
Effect of Degree of Prechallenge Immunity upon Local Antibody Response to Intracerebral 
Challenge Inoculation 
Total 
dosage of 
vaccme 
ml. 
1.8 
0.057 
0.018 
0.OO57 
o.oo18  i 
Sacrificed 
after 
chaUenge! 
dcy$ 
15 
22 
33 
26 
127 
No. cf 
mice 
in po~ I 
10 
12 
10 
Material tested 
for neutralizing 
antibody 
Serum 
Brain 
Serum 
Brain 
Serum 
Brain 
Serum 
Brain 
Serum 
Brain 
Log 
NDig 
2.80 
1.41 
2.91 
1.98 
2.38 
1.55 
2.38 
1.93 
2.41 
2.05 
Serum  [ 
Ratio Brain 
Log  Antilog 
24.6  1.39 
1 
8.5  0.93  ....  1 
6.7  0.83  .... 
1 
2.8  0.45 
1 
2.3 
0.36  -V- 
Titer of complement-fixlng 
antibody 
n,t, 
Pooled sera 1:32 
Pooled brains 1  : 8 
Ratio 
For explanation of figures see Table I. 
n.t., not tested. 
thoroughly immunized animals,  survival would  then  depend more and more 
predominantly on their potential ability to respond to the challenge inoculum 
with local antibody production, and this in turn would be effective only if the 
rate of viral multiplication were not too rapid.  This complex mechanism in 
which viral growth competes with local antibody production probably accounts 
for individual variations often seen among animals vaccinated and challenged 
in the same manner. 
The "Paradoxical" Response of Lightly Immunized Mice to Small 
Intracerebral  Challenge Doses 
Another  observation in  support of the  concept just  discussed  is that  of a 
"paradoxical" response of lightly immunized mice to large or small intracerebral R. w.  SCn'LESmG~R  521 
challenge doses of active virus.  Table IX and Fig. 4 illustrate two examples 
of this.  In both experiments, graded doses of the "slow" Kelser strain were 
injected intracerebrally into mice immunized with very small amounts of vac- 
cine.  Table IX shows that mice vaccinated with 0.0057 or 0.0018 ml. resisted 
105 or 10  ~ LDs0 but that 4 of 8 succumbed after inoculation of 10  ~  LDso.  Simi- 
larly, Fig. 4 shows the response of mice immunized with 0.0006 ml. of vaccine. 
While 10 of 24 mice survived after inoculation of 10  s to IIY LDso of virus, there 
was no sign of protection among mice challenged with smaller amounts (to the 
right of the broken line in Fig. 4) when compared with non-vaccinated controls. 
It  is reasonable  to  assume that the degree of the local immune response 
should depend on the amount of antigen injected.  While in mice with a higher 
degree of immunity small doses of challenge virus may be expected to be effec- 
TABLE IX 
"Paradox~al"  Response to Challenge Doses of W.E.E.  Virus, Slow Strain, in Mice with Low 
Grade Immunity 
Challenge  dose 
Total dose of  LDs0 of W.E.E.-Kelser  virus 
vaccine 
10  6.o  lOS-O  lOt.O 
ml. 
1.8 
0.18 
0. 057 
0. 018 
0.0057 
0.0018 
1/4.  0/4  0/4 
0/4  0/4  0/4 
0/4  0/4  0/4 
0/4  0/4  0/4 
0/4  0/4  9/4 
013  014  214 
* Numerator, number of deaths, denominator, number of mice inoculated. 
tively blocked by the antibody initially present in the brain tissue, in those with 
a very low degree of immunity this amount of antibody must be infinitesimal. 
In the preceding paper (4) the differences in viral growth rate after inoculation 
of various amounts of W.E.E. virus were described.  It was shown that with 
large seed inocula the rates tended to converge while, in the case of the R.I. 
strain, with decreasing inocula there was a  tendency for the rates to parallel 
each other.  It was assumed that with increasing amounts seeded,  a  corre- 
spondingly larger proportion was in excess of that utilized immediately to initi- 
ate infection.  This excess  could then, in  the sensitized animal, act as free 
antigen.  A very small inoculum, on the other hand, if taken up quantitatively 
by susceptible cells, would be ineffective as antigen, with the result that viral 
multiplication could proceed unchecked. 
How delicate this balance between virus increase and immune response may 
be is indicated by the consistently high incidence of transitory encephalitic 
signs among mice with borderline degrees of immunity.  This has been graphi- 522  MECHANISM  O]~ IMMUNITY  TO  ENCEPHALOMYELITIS  VIRUS.  II 
cally illustrated by shading individual squares in Fig. 4.  The mice so symbol- 
ized all had definite  convulsive seizures  and were expected to die.  Instead, 
they recovered completely after a few days or continued to live, sometimes for 
months, with gradually improving partial paralysis of the extremities. 
~DJlul;ion of ~g.E.E.vir,u~  9iven int~ce~eb~cdly 10-1  lO-z  1O's  164 1G510-5  10-7  I(~8 
ii ii 
Non-vaccinated 
mice  I i i,,,,  i  ,,  l:li  D 
• =  1 mouse  dead 
g~=  ',  convulsive  5eizume~- 5umvivecl 
VI=  ,,  no  ~ign~-  ~uf~vivecl 
FIG. 4. "Paradoxical" response to  graded challenge doses of  W.E.E. virus  in  mice with low 
grade immunity. 
RECAPITULATION  AND  DISCUSSION 
While the virus-inactivating and protective action of neutralizing antibody 
is readily evident both in vitro and in passively immunized animals,  its r61e in 
actively immunized hosts has been a subject of doubt and speculation.  This 
has been due to the inability, especially in the case of neurotropic virus infec- 
tions, to consistently correlate varying titers of neutralizing antibody acquired 
as a result of vaccination with corresponding variations in the degree of resist- 
ance to infection.  This has been especially true for those studies in which the 
degree of resistance  was measured  by intracerebral  challenge  inoculation of 
virus.  Thus, conflicting opinions have been expressed concerning  the possible 
significance  of neutralizing  antibody in relation  to cerebral resistance  to the R.  w.  SC~T.v.SmGV.R  523 
viruses of poliomyelitis (12),  equine encephalomyehtis  (1,  13),  St. Louis en- 
cephalitis (13), and rabies (14).  Morgan, Schlesinger, and Olitsky (2) showed 
that vaccinated rabbits were able to resist large intracerebral challenge  doses 
of E.E.  virus provided their  serum contained neutralizing  antibody of high 
titer.  In such animals demonstrable amounts of antibody penetrated into the 
central nervous system, the serum/brain tissue/spinal fluid ratio being of the 
order of 300/3/1.  It was thought that adequate amounts of antibody avail- 
able to the exposed tissue at the time of challenge  were necessary to insure re- 
sistance.  Subsequent finding of a shift in this ratio through an increase in the 
neutralizing titer of brain tissue after challenge  inoculation (3) first suggested 
that local production of antibody might be stimulated by the challenge inoculum 
itself. 
The work reported in this and the preceding paper (4) has revealed a relation- 
ship between local antibody accumulation and survival of immune animals.  It 
has led to the following  conclusions  regarding the mechanism of cerebral im- 
munity to W.E.E. virus:-- 
(a)  The degree of resistance of vaccinated mice to intracerebral  challenge 
inoculation is in part determined by the rate of multiplication of the challenge 
virus. 
(b)  In mice immunized with relatively large doses of vaccine, the difference 
between fast and slow variants of W.E.E. virus is masked, because the high 
initial  concentration of antibody in their serum and central nervous system 
can effectively block or retard the spread of the virus regardless  of its rate of 
multiplication. 
(c)  In  animals  with  lower degrees of immunity,  the amount  of antibody 
initially present may be inadequate to retard significantly  the rate of growth of 
a "fast" variant of the virus.  Because of the rapid rate at which it multiplies 
there may be no chance for local antibody production to be effective in prevent- 
ing fatal infection.  The "slow" variant,  on the other hand,  not only affords 
the immediately available antibody a better chance to react with it, but it also 
gives time for sufficient  additional antibody to be produced locally.  Hence 
even though the virus may multiply and persist in the brain at a relatively high 
level for several days the animal survives. 
(d)  As a  result of this successful  competition of local antibody production 
with viral multiplication,  the serum antibody/brain antibody ratio is consid- 
erably reduced. 
(e)  The degree of this shift in serum/brain ratio varies inversely with the 
initial degree of immunity: the more antibody available initially the greater the 
proportion of the inoculum which is rendered inert as antigen. 
(40 The intensity of the local immune response is also proportional to the 
amount of antigen injected as challenge.  In animals with extremely low grade 
immunity, this may lead to a "paradoxical" response to large and small intra- 524  MECHANISM  OF  IMMUNITY  TO  ENCEPHALOMYELITIS  VIRUS.  II 
cerebral challenge doses: while such animals are sufficiently sensitized to give 
a  rapid  anamnestic  immune response  to  excessive  amounts of virus,  small 
amounts are not sufficiently antigenic and are therefore more apt to cause fatal 
infection. 
The latter finding, in particular, suggests that the antigenic booster effect is 
exerted chiefly by the virus contained in the inoculum itself.  For, as has al- 
ready been pointed out, the growth rate studies (4) lead one to believe that with 
increasing amounts of virus inoculated, correspondingly larger proportions of 
the inoculum exist in excess of the amount utilized to initiate infection.  Pre- 
sumably this excess virus does not attack susceptible cells and is free to stimu- 
late antibody formation.  Similarly, after inoculation of small infectious doses, 
some of the virus liberated by infected cells after multiplication would be free 
to act as antigen but probably too late to affect the outcome; it would be in- 
effective in arresting the course of the infection, especially if, as is probable, the 
virus progressed along the neuronal pathway (15), for in that case virus may 
already have  reached  distant neurons  at  the  time when antibody becomes 
available.  It has been shown by Morgan (12) that non-fatal infection of the 
brain and cord of the monkey with poliomyelitis virus leaves in the wake of its 
neuronal pathway a trail of high neutralizing titers. 
The concept  of  the mechanism of  cerebral  immunity just  outlined  may 
appear complex, but it is in accord with generally accepted principles of immu- 
nology (16).  Local accumulation of specific antibody at the site where antigen 
is deposited has been described by Walsh and Cannon (17) and DeGara and 
Angevine (18) for bacterial agglutinins and by Oerskov and Andersen (19) and 
Hartley  (20) for  antivaccinial antibody.  Similarly,  local  concentration  of 
neutralizing substances, presumably antibody, in the central nervous system 
after infection with viruses has been reported by Fox (7)  for yellow fever in 
mice and by Morgan (12)  for poliomyelitis in monkeys.  The present study 
leaves no doubt that the neutralizing substance present in high concentration 
in the brain tissue of mice immune to and challenged with W.E.E. virus is anti- 
body: (a) it reacts specifically with homologous antigen, (b) it follows the "per- 
centage law" on dilution of underneutralized mixtures, (c)  its concentration in 
relation to that in the serum is paralleled by that of complement-fixing antibody. 
The finding of complement-fixing antibody of high titer in blood-free brain 
tissue is a novel observation in the field of virus diseases.  It is reminiscent of 
the presence of complement-fixing antibody in the cerebrospinal fluid of neuro- 
syphilitic patients.  Kabat, Moore, and Landow, on the basis of electrophoretic 
comparison of serum and cerebrospinal fluid proteins, came to the conclusion 
that this antibody is produced within the central nervous system (21).  This 
interpretation has been favored also by Morgan (12) and Fox (7) for the sys- 
tems studied by them, and evidence presented in this paper lends significant 
support to it: that is the observation that in mice vaccinated with a mixture of R. W.  SCHLESINGER  525 
inactive Western and Eastern E.E. viruses and challenged intracerebrally with 
active virus of either type, the relative concentration of the homologous, but not 
of the heterologous antibody in brain tissue rises.  Such specificity could not 
be expected in doubly immunized animals if the local accumulation of antibody 
were assumed to be due to increased permeability of capillary walls or to some 
non-specific disturbance in the protein balance between blood and brain tissue. 
An interesting problem for further investigation is the reason for the long 
persistence of local antibody in high concentration.  In the present report, 127 
days was the longest interval after intracerebral inoculation of W.E.E. virus 
at which the ratio serum titer/brain titer was examined, and in that particular 
experiment (see Table VIII) it had remained at 2.3/1.  Similarly, Morgan (12) 
found the neutralizing titer against the Lansing strain very high in monkey 
cord as long as 5 months after onset of paralysis.  Earlier observations on the 
markedly delayed onset of encephalitis in W.E.E.-infected guinea pigs treated 
with large doses of hyperimmune serum (22)  suggested that in passively im- 
mune animals the virus  sometimes persisted  in  the  central nervous  system 
masked by antibody which blocked the development of active immunity.  In 
contrast, persistence of antigen in actively immune animals may be responsible 
for continued presence of local antibody in high titer. 
The "paradoxical" type of response of mice with low degree of immunity to 
various amounts of active virus, i.e.  their failure to survive minimal challenge 
doses although they can resist large ones, is not without parallel.  Casals (23) 
and Habel and Wright (24) have noted the same phenomenon in mice vacci- 
nated and challenged with rabies virus, and the explanation given here for the 
findings with W.E.E. virus may apply equally for rabies. 
In general, there is no reason to believe that the principles found to govern 
the mechanism of cerebral immunity to W.E.E. virus should not be applicable 
to the wider field of other virus infections of the central nervous system and of 
other organ systems.  The findings reported in the preceding paper (4) and in 
this one reaffirm that the actively immunized animal differs from the normal 
one not in principle but only in its greater ability to respond to an antigenic 
stimulus.  The fate of the immune host after challenge--even that of the mouse 
inoculated intracerebrally with W.E.E.  virus--is not either  death or  intact 
survival.  There may be any intermediate degree of involvement.  What hap- 
pens is determined by a delicate quantitative balance with relation to (a) degree 
of initial immunity or sensitization, (b) amount of the challenge virus, (c) rate of 
its multiplication, (d)  ability of the host to respond with local antibody pro- 
duction. 
SUMMAI~¥ 
The fate of W.E.E. virus has been followed in the brains of mice vaccinated 
to such an extent that they failed to resist a large intracerebral challenge dose 526  MECHANISM  OF  IMMUNITY  TO  ENCEPHALOMYELITIS  VIRUS.  II 
of a viral variant with a rapid rate of multiplication but were fully protected 
against a similar amount of a  "slow" strain. 
The growth rate of the "fast" variant in vaccinated animals paralleled that 
in non-vaccinated ones at a slightly lower level.  The "slow" strain also multi- 
plied, but its rate of growth was depressed.  Nevertheless, it persisted for 4 
days at a  level 100-fold higher than its initial titer. 
After the 4th day the virus was no longer demonstrable and was replaced by 
neutralizing antibody which rose so high that the serum antibody/brain anti- 
body ratio was reduced from a  "physiological" value of  about 200/1  to less 
than 10/1.  Antibody persisted in brain tissue in high titer until at least 127 
days after challenge inoculation. 
The shift in the serum/brain ratio of neutralizing antibody was paralleled 
by a similar shift in the ratio of complement-fixing antibody. 
The neutralizing antibody in brain tissue, like that in serum, followed the 
"percentage law" on dilution of underneutralized mixtures. 
In mice immunized with small doses of vaccine, the intracerebral challenge 
inoculum induced a  significantly greater local immune response than in those 
immunized to a higher degree. 
Mice with very low  grade  immunity were found more  resistant  to  large 
amounts of virus  than  to  small amounts.  This  "paradoxical" response  to 
challenge was  explained  as  due  to  the  antigenic  booster  effect exerted by 
amounts of virus in excess of that utilized to initiate infection which were pres- 
ent in large inocula but absent in small doses. 
The broader relation of these findings to the problem of antiviral immunity 
has been discussed. 
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